COVID-19: Which Drug, When, and Why?

Hear expert insights on the role and timing of anti-inflammatory agents and immunomodulators such as corticosteroids, IL-6 inhibitors, and JAK inhibitors in the treatment of COVID-19.

Vikramjit Mukherjee, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 7, 2022 Expired: No longer available for credit

Downloadable slideset including the latest data on the use of anti-inflammatory agents and immunomodulators for the treatment of COVID-19.

Vikramjit Mukherjee, MD Released: April 7, 2022

Listen to expert discussion on the role and timing of antiviral agents for COVID-19, including considerations for inpatient or outpatient use and use in different age groups.

David A. Wohl, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 25, 2022 Expired: No longer available for credit

Downloadable slideset including the latest data on the use of antiviral agents for the treatment of COVID-19.

David A. Wohl, MD Released: April 25, 2022

Hear expert insights on the role and timing of monoclonal antibody treatments for COVID-19, including specific considerations related to omicron and its subvariants.

Gregory Huhn, MD, MPHTM Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 15, 2022 Expired: No longer available for credit

Downloadable slideset including the latest data on the use of monoclonal antibodies for the treatment and prophylaxis of COVID-19.

Gregory Huhn, MD, MPHTM Released: April 15, 2022

When a patient presents with critical illness from COVID-19, sometimes we must use every drug in our armamentarium to save their life.

Vikramjit Mukherjee, MD Released: May 3, 2022

In which patients with COVID-19 should we use anti-inflammatory agents and immunomodulators? Hear expert insights on the timing and role of convalescent plasma, corticosteroids, IL-6 inhibitors, and JAK inhibitors in the treatment of COVID-19.

Vikramjit Mukherjee, MD Released: April 7, 2022

What is the role and timing of antiviral agents for COVID-19? Listen to expert insights on considerations for inpatient or outpatient use and use in different age groups.

David A. Wohl, MD Released: April 25, 2022

In which patients with COVID-19 should we use monoclonal antibodies as prophylaxis or treatment? Hear expert insights on the timing and role of monoclonal antibody treatments for COVID-19 during the omicron era.

Gregory Huhn, MD, MPHTM Released: April 21, 2022